XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Payments: (Tables)
3 Months Ended
Mar. 31, 2025
Equity:  
The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2025:

 

    Number of Shares     Weighted Average Grant-Date Fair Value  
Nonvested options – beginning of period     118,650     $ 30.02  
Nonvested options granted            
Nonvested options vested or forfeited     (4,900 )   $ 22.41  
Nonvested options – end of period     113,750     $ 30.35  
The following table summarizes stock option information as of March 31, 2024:

The following table summarizes stock option information as of March 31, 2025:

 

    Shares     Weighted Average
Exercise Price
 
             
Outstanding at January 1, 2025     246,430     $ 103.24  
Options forfeited     (3,800 )     124.09  
Options exercised     (13,830 )     77.88  
                 
Outstanding at March 31, 2025     228,800     $ 104.43  
                 
Options exercisable     115,050     $ 82.06  
Options available for future grants     498,195          
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2025 and 2024 were as follows:

 

(In thousands)   March 31, 2025     March 31, 2024  
             
Cash proceeds from stock options exercised   $ 1,077     $ 1,326  
Tax benefits     125       220  
Intrinsic value of stock options exercised     840       1,375